During Wednesday’s Current trade, Shares of Teradyne, Inc. (NYSE:TER), lost -0.69% to $17.99.
Teradyne, Inc. (TER) and Intellitech Corp. declared they have demonstrated an improvement in the silicon validation time for System-on-a-Chip (SoC) devices. Engineering teams from the two companies collaborated using the IEEE 1149.1-2013 standard with Teradyne’s UltraFLEX digital instruments and Intellitech’s NEBULA silicon debugger on a state-of-the-art SoC device. The IP cores in the SoC device were debugged in hours rather than weeks by simplifying engineers’ interaction with the IP cores through hierarchical access and high-level commands. This approach also allowed pre-silicon simulation and more compact test files contrast to a traditional, vector-based methodology.
“Customers striving to gain a time-to-market leap are now specifically requesting that their IP vendors provide pre-verified IEEE 1149.1-2013 compliant documentation. They realize this new standard for IP documentation, IEEE 1149.1 Procedural Description Language (PDL), offers noteworthy advantages in portability and reusability between the pre-silicon verification environment and post silicon debug on the UltraFLEX,” said CJ Clark, CEO, Intellitech Corp. “With the same PDL documentation and the same software interface, many variables normally presented to the engineer during traditional silicon bring-up, were eliminated.”
Teradyne, Inc. provides automatic test equipment worldwide. The company’s Semiconductor Test segment designs, manufactures, sells, and supports semiconductor test products and services for wafer level and device package testing in automotive, industrial, communications, consumer, computer and electronic game applications, and others. This segment offers FLEX test platform systems; Magnum test platform that tests memory devices, such as flash memory and dynamic random access memory; J750 test system to address the highest volume semiconductor devices; and ETS platform for use by semiconductor manufacturers, and assembly and test subcontractors in the low pin count analog/mixed signal discrete markets. It serves integrated device manufacturers (IDMs) that integrate the fabrication of silicon wafers into their business; fabless companies, which outsource the manufacturing of silicon wafers; foundries that cater to the processing and manufacturing of silicon wafers; and outsourced semiconductor assembly and test providers, which offer test and assembly services for the final packaged devices to fabless companies and IDMs.
Shares of Principal Financial Group Inc (NYSE:PFG), inclined 0.10% to $48.86, during its current trading session.
Principal Financial Group, Inc. (PFG) recently declared results for second quarter 2015.
- Operating earnings raised to $323.9 million for second quarter 2015, contrast to $323.1 million for second quarter 2014. After adjusting for normalizing items and foreign exchange rates, operating earnings raised 10 percent over second quarter 2014. Operating earnings per diluted share (EPS) raised 1 percent to $1.09 for second quarter 2015, contrast to $1.08 for second quarter 2014.
- Net income accessible to common stockholders for second quarter 2015 reduced to $241.1 million, or 81 cents per diluted share, contrast to $306.3 million, or $1.03 per diluted share for second quarter 2014.
- Operating revenues raised 34 percent in second quarter 2015 to $3,406.8 million from higher sales and fee income, contrast to $2,542.6 million for second quarter 2014.
- Fee income3 raised 6 percent to $908.5 million for the second quarter 2015, contrast to $855.3 million for second quarter 2014.
Principal Financial Group, Inc. provides retirement, asset administration, and insurance products and services. It operates through Retirement and Investor Services, Principal Global Investors, Principal International, and U.S. Insurance Solutions segments. The Retirement and Investor Services segment provides a portfolio of asset accumulation products and services for retirement savings and investment to businesses, institutional clients, and employees of business and other individuals.
Raytheon Company (NYSE:RTN), during its Wednesday’s current trading session gained 0.45% to $106.98.
Raytheon Company (RTN) declared net sales for the second quarter 2015 were $5.8 billion contrast to $5.7 billion in the second quarter 2014. Second quarter 2015 EPS from ongoing operations was $1.65 contrast to $1.59 in the second quarter 2014. Second quarter 2015 EPS from ongoing operations comprised of a favorable FAS/CAS Adjustment of $0.10 contrast to a favorable FAS/CAS Adjustment of $0.18 in the second quarter 2014. In addition, second quarter 2015 EPS from ongoing operations comprised of, as predictable, a $0.29 favorable impact from a tax settlement.
The Company had bookings of $7.6 billion in the second quarter 2015, resulting in a book-to-bill ratio of 1.30. In the second quarter 2014, bookings were $6.8 billion. Year-to-date 2015 bookings were $12.1 billion, resulting in a book-to-bill ratio of 1.08. Year-to-date 2014 bookings were $11.1 billion.
Raytheon Company develops integrated products, services, and solutions in the areas of sensing; effects; command, control, communications, and intelligence; mission support; and cyber and information security worldwide. It operates in four segments: Integrated Defense Systems (IDS); Intelligence, Information, and Services (IIS); Missile Systems (MS); and Space and Airborne Systems (SAS). The IDS segment provides integrated air and missile defense; radar solutions; naval combat and ship electronic systems; command, control, communications, computers, and intelligence solutions; and air traffic administration systems.
Finally, Unilife Corp (NASDAQ:UNIS), decreased -4.96%, to $1.25.
Unilife Corporation ( UNIS), a developer, manufacturer and supplier of injectable drug delivery systems, recently declared the implementation of a multifaceted financing strategy that provides the Company with flexibility and control to support its continued business growth.
Unilife has signed an equity purchase agreement for up to $45 million with Lincoln Park Capital Fund, LLC (“LPC”), a Chicago-based institutional investor, which provides the Company with $5 million in initial net proceeds and the option to generate, at its sole control and discretion, up to $40 million in additional net proceeds over 24 months. Unilife has also implemented a $25 million At-the-Market facility with Cantor Fitzgerald that can be used at the Company’s discretion.
Unilife Corporation designs, manufactures, and supplies injectable drug delivery systems in the United States and internationally. The company offers Unifill, a pre-filled syringe with integrated, automatic, and user-controlled retraction; Unifill Finesse, an integrated, automatic, and user-controlled retraction with standard plunger seal and plunger rod; Unifill Select, which allows an end-user to select and attach a needle at the time of injection; Unifill Nexus that is equipped with an integrated luer adapter to provide connectivity with needleless luer access devices; and Unifill Allure, which combines universal luer connectivity with automatic, user-controlled needle retraction.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
